Moreover, we preliminary explored the interaction of collagen, chemokines such as CXCL9, CXCL10, and CXCL11, and TAM in TME through coexpression analysis of transcriptome data associated with stromal and immune signatures and may, therefore, provide novel prognostic biomarkers and immunotherapeutic targets for STAD. This evidence concerns the gene CXCL11 and gastric adenocarcinoma.